Aleplasinin is an experimental drug belonging to the class of plasminogen activator inhibitors (PAI-1 inhibitors). It is being developed by the U.S. pharmaceutical company Wyeth for potential use in the treatment of Alzheimer's disease.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.